Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

170 recalls · Class III, newest first

Class III · Low risk

Nebivolol Tablets

Cross Contamination with Other Products

Ongoing Cross-contamination Glenmark Pharmaceuticals Inc., USA NDC 42291-874-90 D-0222-2026
Class III · Low risk

Varenicline Tablets

Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.

Ongoing Wrong potency / content Dr. Reddy's Laboratories, Inc. NDC 43598-908-56 D-0219-2026
Class III · Low risk

Fesoterodine Fumarate

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Ongoing Impurity / degradation Alembic Pharmaceuticals Limited NDC 62332-175-30 D-0156-2026
Class III · Low risk

Everolimus tablets 5mg

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Ongoing Impurity / degradation Endo USA, Inc. NDC 49884-125-91 D-0139-2026
Class III · Low risk

FentaNYL Citrate PF

Labeling: Incorrect or Missing Lot and/or Exp Date

Ongoing Labeling / mix-up STAQ Pharma, Inc. NDC 73177-0102-05 D-0025-2026
Class III · Low risk

Espumil

Labeling: Not Elsewhere Classified

Ongoing Labeling / mix-up Letco Medical LLC D-0138-2026

Recalls by year